Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock

NCT07569536 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Septic Shock, Vasopressor Resistance

Interventions

DRUG: Dexmedetomidine 100 µg/mL, intravenous solution
OTHER: Stardard care

Sponsor

Hospices Civils de Lyon

Collaborators

[object Object]